James Kelly Ganjei - Mar 21, 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ James Kelly Ganjei
Stock symbol
INMB
Transactions as of
Mar 21, 2022
Transactions value $
$149,995
Form type
4
Date filed
3/23/2022, 04:29 PM
Previous filing
Jun 24, 2021
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Award $150K +17.8K $8.43 17.8K Mar 22, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +35K $0.00 35K Mar 21, 2022 Common Stock 35K $7.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities. These shares were purchased by the Reporting Person directly from Issuer.
F2 Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.